This company has been marked as potentially delisted and may not be actively trading. Arena Pharmaceuticals (ARNA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ARNA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Neuvivo makes bid to enter ALS arena with immunotherapy candidateOctober 7, 2024 | msn.comArwana Citramulia Tbk (ARNA)August 31, 2023 | uk.investing.comMLS club places Bruce Arena on leave over probe into 'allegations of insensitive and inappropriate remarks'August 21, 2023 | foxnews.comRNA startup launches with $300M, Merck partnershipMay 23, 2023 | bizjournals.comLongboard Pharmaceuticals: Undervalued Arena Spin-Out Has 2 Data Catalysts Due In 2023May 23, 2023 | seekingalpha.comPfizer earnings and revenue top expectations despite Covid vaccine sales declineMay 6, 2023 | cnbc.comArna L. DavidsonApril 25, 2023 | health.usnews.comPortland, Maine, reopens basketball arena to migrantsApril 12, 2023 | foxnews.comIs Pfizer Stock Undervalued At $40?March 17, 2023 | forbes.comArna Marketing Group Continues Investing in State-of-the-art Canon Inkjet Technology to Deliver "The Arna Advantage"February 9, 2023 | benzinga.comArna Marketing Group Continues Investing in State-of-the-art Canon Inkjet Technology to Deliver “The Arna Advantage”February 8, 2023 | finance.yahoo.comA DNA protein may be responsible for causing cancerous ‘stress balls’ in the body: U of S researchFebruary 6, 2023 | msn.comObesity Drugs: The Road to PerditionAugust 23, 2022 | thestreet.comPfizer to Buy Global Blood TherapeuticsAugust 8, 2022 | baystreet.caShould You Buy Pfizer Stock After An Upbeat Q2?August 4, 2022 | forbes.comShould You Buy, Sell, Or Hold Pfizer Stock At $52?June 29, 2022 | forbes.com7 Biotech Stocks With Key Catalysts in MarchMay 3, 2022 | theglobeandmail.comArena Pharmaceuticals (Nasdaq:ARNA) HeadlineTrading was temporarily halted for "ARNA" at 07:03 PM with a stated reason of "News pending."...March 11, 2022 | marketbeat.comPfizer confirms HSR waiting period for Arena Pharmaceuticals deal expiredMarch 10, 2022 | seekingalpha.comArena Pharma gains after report Pfizer deal will clear without HSR second requestMarch 7, 2022 | seekingalpha.comArena Pharmaceuticals GAAP EPS of -$2.54 misses by $0.31February 25, 2022 | seekingalpha.comArena (ARNA) Q4 Loss Wider Than Expected, Etrasimod in FocusFebruary 24, 2022 | msn.comSFO opens criminal probe into collapse of Arena TelevisionFebruary 23, 2022 | uk.finance.yahoo.comArena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program UpdatesFebruary 23, 2022 | finance.yahoo.comArena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23February 9, 2022 | finance.yahoo.comHC Wainwright & Co. Downgrades Arena Pharmaceuticals to Neutral, Lowers Price Target to $100February 9, 2022 | benzinga.comExpert Ratings For Arena PharmaceuticalsFebruary 9, 2022 | markets.businessinsider.comHC Wainwright Reaffirms "Neutral" Rating for Arena Pharmaceuticals (NASDAQ:ARNA)February 9, 2022 | marketbeat.comNotable Tuesday Option Activity: ARNA, MSGE, POWWFebruary 8, 2022 | nasdaq.comDid The Smart Money Play Arena Pharmaceuticals, Inc. (ARNA) Correctly?February 6, 2022 | finance.yahoo.comIntegral Health Asset Management, LLC Buys McKesson Corp, Centene Corp, Abbott Laboratories,February 2, 2022 | finance.yahoo.comHavens Advisors Llc Buys BHP Group PLC, CyrusOne Inc, NeoPhotonics Corp, Sells , ,January 31, 2022 | finance.yahoo.com3 Clinical Trials to Watch in the First Half of 2022January 22, 2022 | msn.comArena (ARNA) Stock Up in 6 Months on PFE Merger Deal & PipelineJanuary 18, 2022 | finance.yahoo.comArena Pharmaceuticals (NASDAQ:ARNA) Upgraded to Buy by Zacks Investment ResearchJanuary 12, 2022 | marketbeat.comArena Pharmaceuticals Inc Shares Close in on 52-Week High - Market MoverJanuary 8, 2022 | nasdaq.comStockholder Sues To Block Pfizer's $6.7B Arena Pharma BuyJanuary 7, 2022 | law360.comIs Pfizer's Acquisition of Arena a Good Move for Investors?January 3, 2022 | fool.comAre Options Traders Betting on a Big Move in Arena (ARNA) Stock?January 3, 2022 | finance.yahoo.comArena Pharmaceuticals, Inc. (NASDAQ:ARNA) Receives Consensus Rating of "Hold" from AnalystsDecember 28, 2021 | marketbeat.comPfizer’s Arena Pharma deal may lead drug company to a cannabis-based treatmentDecember 23, 2021 | finance.yahoo.comShould You Buy Arena Pharmaceuticals, Inc. (ARNA) After Golden Cross?December 22, 2021 | finance.yahoo.comArena Pharmaceuticals (NASDAQ:ARNA) Stock Rating Lowered by Cantor FitzgeraldDecember 20, 2021 | marketbeat.comPfizer: Arena Acquisition to Unlock New Growth OpportunitiesDecember 16, 2021 | nasdaq.comARENA MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Arena Pharmaceuticals, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm - ARNADecember 16, 2021 | finance.yahoo.comAbivax: Potentially The Next Arena Pharmaceuticals, Most Ideal Big Pharma M&A Target In 2022December 15, 2021 | seekingalpha.comArena Pharmaceuticals INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNADecember 14, 2021 | prnewswire.comPfizer Set to Acquire Arena Pharmaceuticals for $6.7 BillionDecember 14, 2021 | finance.yahoo.comWhat 6 Analyst Ratings Have To Say About Arena PharmaceuticalsDecember 14, 2021 | markets.businessinsider.comPfizer (PFE) to Buy Arena, Boost Immuno-Inflammatory PipelineDecember 14, 2021 | finance.yahoo.com Get Arena Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARNA Media Mentions By Week ARNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARNA News Sentiment▼0.000.99▲Average Medical News Sentiment ARNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARNA Articles This Week▼00▲ARNA Articles Average Week Get the Latest News and Ratings for ARNA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arena Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Biogen News Incyte News United Therapeutics News Neurocrine Biosciences News BioMarin Pharmaceutical News Exelixis News Madrigal Pharmaceuticals News Exact Sciences News Halozyme Therapeutics News Repligen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARNA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arena Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arena Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access